Warning! GuruFocus detected
6 Severe warning signs
with 2TX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Asensus Surgical Inc
NAICS : 339112
SIC : 3841
ISIN : US89366M2017
Share Class Description:
FRA:2TX: Ordinary SharesDescription
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.38 | |||||
| Equity-to-Asset | -0.29 | |||||
| Debt-to-Equity | -1.8 | |||||
| Debt-to-EBITDA | -0.27 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -42.28 | |||||
| Beneish M-Score | -5.08 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.9 | |||||
| 3-Year EBITDA Growth Rate | 23.5 | |||||
| 3-Year EPS without NRI Growth Rate | 26.9 | |||||
| 3-Year FCF Growth Rate | 26.9 | |||||
| 3-Year Book Growth Rate | -38.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 34.93 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 81.62 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.74 | |||||
| 9-Day RSI | 56.99 | |||||
| 14-Day RSI | 54.69 | |||||
| 6-1 Month Momentum % | 14.25 | |||||
| 12-1 Month Momentum % | 27.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.49 | |||||
| Quick Ratio | 0.31 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 204.85 | |||||
| Days Sales Outstanding | 43.81 | |||||
| Days Payable | 108.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -31.6 | |||||
| Shareholder Yield % | -15.64 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -30.45 | |||||
| Operating Margin % | -723.08 | |||||
| Net Margin % | -850.75 | |||||
| FCF Margin % | -581.65 | |||||
| ROE % | -291.24 | |||||
| ROA % | -145.74 | |||||
| ROIC % | -191.44 | |||||
| 3-Year ROIIC % | 87.3 | |||||
| ROC (Joel Greenblatt) % | -503.58 | |||||
| ROCE % | -204.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9.4 | |||||
| EV-to-EBIT | -1.36 | |||||
| EV-to-EBITDA | -1.43 | |||||
| EV-to-Revenue | 10.92 | |||||
| EV-to-Forward-Revenue | 7.51 | |||||
| EV-to-FCF | -1.89 | |||||
| Price-to-GF-Value | 0.68 | |||||
| Earnings Yield (Greenblatt) % | -73.53 | |||||
| FCF Yield % | -60.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Asensus Surgical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 9.083 | ||
| EPS (TTM) (€) | -0.279 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.14 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 76.3 | ||
| 14-Day RSI | 54.69 | ||
| 14-Day ATR (€) | 0.024099 | ||
| 20-Day SMA (€) | 0.278455 | ||
| 12-1 Month Momentum % | 27.28 | ||
| 52-Week Range (€) | 0.1701 - 0.38 | ||
| Shares Outstanding (Mil) | 272.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Asensus Surgical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Asensus Surgical Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Asensus Surgical Inc Frequently Asked Questions
What is Asensus Surgical Inc(FRA:2TX)'s stock price today?
The current price of FRA:2TX is €0.31. The 52 week high of FRA:2TX is €0.38 and 52 week low is €0.17.
When is next earnings date of Asensus Surgical Inc(FRA:2TX)?
The next earnings date of Asensus Surgical Inc(FRA:2TX) is 2025-05-14 Est..
Does Asensus Surgical Inc(FRA:2TX) pay dividends? If so, how much?
Asensus Surgical Inc(FRA:2TX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers